Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Accutane

Isotretinoin

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Accutane:

 BioPortfolio Logo
NJLRA Statement in Response to Roche's Discontinuation of Accutane(R) 26th June, 2009 New Jersey Lawsuit Reform Alliance
TRENTON, N.J., June 26 /PRNewswire/ -- Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, a statewide, bipartisan group of individuals, businesses and organizations dedicated
Arava: the 'sixth drug' that may soon be under fire 1st April, 2004 Datamonitor
Arava: the 'sixth drug' that may soon be under fire At a recent hearing into the Vioxx affair, the FDA's Dr David Graham named five drugs that he considers too dangerous to be on the market.
Serevent warning focuses attention on the need for combination therapy 1st August, 2003 Datamonitor
Serevent warning focuses attention on the need for combination therapy The recent announcement by the FDA's associate director for science and medicine that sales of GlaxoSmithKline's asthma

This page has been viewed 22 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Accutane across BioPortfolio, or for Accutane Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.